Edgewise Therapeutics, Inc.
EWTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001710072
In the last 90 days, Edgewise Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $4.82B in total; no superinvestor holds it.
13F holders, Q1 2021
Institutional positions in Edgewise Therapeutics, Inc. as of Mar 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- No complete 13F data for Q4 2020
- Shares held
- 45.7M
- No complete 13F data for Q4 2020
- Total value
- $1.48B
- No complete 13F data for Q4 2020
Holders and value by quarter
Institutions reporting EWTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 226 | $4.82B |
| Q1 2026 | 214 | $3.72B |
| Q4 2025 | 199 | $3.02B |
| Q3 2025 | 173 | $1.82B |
| Q2 2025 | 179 | $1.56B |
| Q1 2025 | 193 | $2.32B |
| Q4 2024 | 201 | $2.64B |
| Q3 2024 | 177 | $2.71B |
| Q2 2024 | 140 | $1.83B |
| Q1 2024 | 129 | $1.67B |
| Q4 2023 | 116 | $871.4M |
| Q3 2023 | 85 | $392.2M |
| Q2 2023 | 95 | $538.8M |
| Q1 2023 | 85 | $443.1M |
| Q4 2022 | 90 | $594.1M |
| Q3 2022 | 94 | $633.5M |
| Q2 2022 | 78 | $405.7M |
| Q1 2022 | 72 | $523.5M |
| Q4 2021 | 58 | $769.4M |
| Q3 2021 | 48 | $795.8M |
| Q2 2021 | 46 | $1.03B |
| Q1 2021 | 31 | $1.48B |
Institutions, Q1 2021
Shares, value and share of portfolio for each institution holding Edgewise Therapeutics, Inc..
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 13,944,680 | $453.2M | 4.28% | – | – |
| Novo Holdings A/S | 5,587,207 | $181.6M | 7.50% | – | – |
| Deerfield Management Company, L.P. (Series C) | 3,933,137 | $127.8M | 2.69% | – | – |
| Viking Global Investors LPSuperinvestorViking Global Investors | 3,352,249 | $108.9M | 0.32% | – | – |
| Ra Capital Management, L.P. | 2,613,623 | $84.9M | 1.28% | – | – |
| Citadel Advisors LLC | 2,382,148 | $77.4M | 0.08% | – | – |
| Cormorant Asset Management, LP | 2,340,914 | $74.3M | 2.14% | – | – |
| Janus Henderson Group PLC | 2,140,908 | $65.1M | 0.03% | – | – |
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $50.5M | 11.75% | – | – |
| FMR LLC | 1,530,418 | $49.7M | 0.00% | – | – |
| EcoR1 Capital, LLC | 1,224,175 | $39.8M | 1.78% | – | – |
| Logos Global Management LP | 1,056,812 | $34.3M | 3.35% | – | – |
| Wellington Management Group LLP | 742,412 | $23.1M | 0.00% | – | – |
| Federated Hermes, Inc. | 616,724 | $20.0M | 0.04% | – | – |
| Baker Bros. Advisors LP | 500,000 | $16.3M | 0.07% | – | – |
| Norges Bank | 449,000 | $14.6M | 0.00% | – | – |
| Woodline Partners LP | 357,429 | $11.6M | 0.26% | – | – |
| Adage Capital Partners GP, L.L.C. | 300,000 | $9.75M | 0.02% | – | – |
| American Century Companies Inc | 278,577 | $9.05M | 0.01% | – | – |
| Octagon Capital Advisors LP | 125,000 | $4.06M | 1.53% | – | – |
| Vanguard Group Inc | 120,000 | $3.90M | 0.00% | – | – |
| Sphera Funds Management Ltd. | 100,000 | $3.25M | 0.30% | – | – |
| Soleus Capital Management, L.P. | 100,000 | $3.25M | 0.59% | – | – |
| Credit Suisse AG | 84,052 | $2.73M | 0.00% | – | – |
| Goldman Sachs Group Inc | 65,263 | $2.12M | 0.00% | – | – |
| Millennium Management LLC | 60,077 | $1.95M | 0.00% | – | – |
| BlackRock Inc. | 55,485 | $1.80M | 0.00% | – | – |
| Caas Capital Management LP | 30,000 | $975.0K | 0.03% | – | – |
| Squarepoint Ops LLC | 20,185 | $656.0K | 0.01% | – | – |
| Landscape Capital Management, L.L.C. | 8,923 | $290.0K | 0.05% | – | – |
| Maven Securities LTD | 8,300 | $262.0K | 0.02% | – | – |